Abiopharma

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

New SEC Filing for Avanos Medical Inc. (NYSE:AVNS)

LifeMD to Report Third Quarter 2025 Financial Results on November 6

Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

Ginkgo Bioworks - Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-Hs EMBODY Program

EPAM Systems, Inc. - EPAM LaunchesAI/Run™.Transform to Accelerate AI-Native Transformation for the Enterprise

Integer Holdings Corporation - Integer Holdings Corporation Reports Third Quarter 2025 Results

BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society

Esperion to Report Third Quarter 2025 Financial Results on November 6

Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025

Mallinckrodt plc to Report Third Quarter 2025 Financial Results on November 10, 2025

Gilead - Gilead to Showcase Interim Long-Term Efficacy Data forLivdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta

Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6

Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer

Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting